2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial

Gallwitz, Baptist; Rosenstock, Julio; Rauch, Thomas; Bhattacharya, Sudipta; Patel, Sanjay; von Eynatten, Maximilian; Dugi, Klaus A.; Woerle, Hans-Juergen

dc.contributor.author	Gallwitz, Baptist	de_DE
dc.date.accessioned	2014-03-10T11:09:40Z
dc.date.available	2014-03-10T11:09:40Z
dc.date.issued	2012	de_DE
dc.identifier.issn	0140-6736	de_DE
dc.identifier.uri	http://hdl.handle.net/10900/43217
dc.language.iso	en	en
dc.publisher	Elsevier Science Inc	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/S0140-6736(12)60691-6	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140226071329_01444	de_DE
utue.publikation.seiten	475-483	de_DE
utue.personen.roh	Gallwitz, Baptist	de_DE
utue.personen.roh	Rosenstock, Julio	de_DE
utue.personen.roh	Rauch, Thomas	de_DE
utue.personen.roh	Bhattacharya, Sudipta	de_DE
utue.personen.roh	Patel, Sanjay	de_DE
utue.personen.roh	von Eynatten, Maximilian	de_DE
utue.personen.roh	Dugi, Klaus A.	de_DE
utue.personen.roh	Woerle, Hans-Juergen	de_DE
dcterms.isPartOf.ZSTitelID	Lancet	de_DE
dcterms.isPartOf.ZS-Issue	9840	de_DE
dcterms.isPartOf.ZS-Volume	380	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE